BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

181 related articles for article (PubMed ID: 30709755)

  • 1. IUGR: Genetic influences, metabolic problems, environmental associations/triggers, current and future management.
    Darendeliler F
    Best Pract Res Clin Endocrinol Metab; 2019 Jun; 33(3):101260. PubMed ID: 30709755
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The Association of Accelerated Early Growth, Timing of Puberty, and Metabolic Consequences in Children.
    Jee YH; Jumani S; Mericq V
    J Clin Endocrinol Metab; 2023 Aug; 108(9):e663-e670. PubMed ID: 37029976
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Fetal nutrition and timing of puberty.
    van Weissenbruch MM; Engelbregt MJT; Veening MA; Delemarre-van de Waal HA
    Endocr Dev; 2005; 8():15-33. PubMed ID: 15722615
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Exercise as an intervention to improve metabolic outcomes after intrauterine growth restriction.
    Gatford KL; Kaur G; Falcão-Tebas F; Wadley GD; Wlodek ME; Laker RC; Ebeling PR; McConell GK
    Am J Physiol Endocrinol Metab; 2014 May; 306(9):E999-1012. PubMed ID: 24619880
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Update: consequences of abnormal fetal growth.
    Chernausek SD
    J Clin Endocrinol Metab; 2012 Mar; 97(3):689-95. PubMed ID: 22238390
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Serum adiponectin levels, insulin resistance, and lipid profile in children born small for gestational age are affected by the severity of growth retardation at birth.
    Evagelidou EN; Giapros VI; Challa AS; Kiortsis DN; Tsatsoulis AA; Andronikou SK
    Eur J Endocrinol; 2007 Feb; 156(2):271-7. PubMed ID: 17287418
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Intra-uterine Growth Retardation as a Risk Factor of Postnatal Metabolic Disorders.
    Mierzynski R; Dluski D; Darmochwal-Kolarz D; Poniedziałek-Czajkowska E; Leszczynska-Gorzelak B; Kimber-Trojnar Z; Agnieszka-Wankowicz ; Oleszczuk J
    Curr Pharm Biotechnol; 2016; 17(7):587-96. PubMed ID: 26927210
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Genetic, metabolic and endocrine aspect of intrauterine growth restriction: an update.
    Sharma D; Sharma P; Shastri S
    J Matern Fetal Neonatal Med; 2017 Oct; 30(19):2263-2275. PubMed ID: 27718783
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Intrauterine growth retardation and puberty in girls.
    Voordouw JJ; van Weissenbruch MM; Delemarre-van de Waal HA
    Twin Res; 2001 Oct; 4(5):299-306. PubMed ID: 11869480
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Short-term and long-term sequelae in intrauterine growth retardation (IUGR).
    Longo S; Bollani L; Decembrino L; Di Comite A; Angelini M; Stronati M
    J Matern Fetal Neonatal Med; 2013 Feb; 26(3):222-5. PubMed ID: 23030765
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Fetal growth restriction and insulin resistance. New findings and review of the literature].
    Soto I N; Mericq G V
    Rev Med Chil; 2005 Jan; 133(1):97-104. PubMed ID: 15768156
    [TBL] [Abstract][Full Text] [Related]  

  • 12. What's new in IUGR from the endocrinological point of view?
    Korpysz A; Szalecki M
    Pediatr Endocrinol Diabetes Metab; 2019; 25(4):188-193. PubMed ID: 32270973
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Amplitude of pubertal growth in short stature children with intrauterine growth retardation.
    Lienhardt A; Carel JC; Preux PM; Coutant R; Chaussain JL
    Horm Res; 2002; 57 Suppl 2():88-94. PubMed ID: 12065935
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Body mass index at the presentation of premature adrenarche is associated with components of metabolic syndrome at puberty.
    Kaya G; Yavas Abali Z; Bas F; Poyrazoglu S; Darendeliler F
    Eur J Pediatr; 2018 Nov; 177(11):1593-1601. PubMed ID: 30056577
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Intrauterine Growth Restriction: Postnatal Monitoring and Outcomes.
    Kesavan K; Devaskar SU
    Pediatr Clin North Am; 2019 Apr; 66(2):403-423. PubMed ID: 30819345
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Experimental IUGR and later diabetes.
    Martin-Gronert MS; Ozanne SE
    J Intern Med; 2007 May; 261(5):437-52. PubMed ID: 17444883
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Changes in circulating miRNA19a-3p precede insulin resistance programmed by intra-uterine growth retardation in mice.
    Saget S; Cong R; Decourtye L; Endale ML; Martinerie L; Girardet C; Perret C; Clemessy M; Leneuve P; Dinard L; Mohand Oumoussa B; Farabos D; Lamazière A; Lombès M; Moldes M; Fève B; Tregouet D; Le Bouc Y; Kappeler L
    Mol Metab; 2020 Dec; 42():101083. PubMed ID: 32956848
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Endocrine-related causes and consequences of intrauterine growth retardation.
    Kanaka-Gantenbein C; Mastorakos G; Chrousos GP
    Ann N Y Acad Sci; 2003 Nov; 997():150-7. PubMed ID: 14644821
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Impact of intrauterine growth restriction on long-term health.
    Salam RA; Das JK; Bhutta ZA
    Curr Opin Clin Nutr Metab Care; 2014 May; 17(3):249-54. PubMed ID: 24613859
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Biochemistry, hormones and adipocytokines in prepubertal children born with IUGR evoke metabolic, hepatic and renal derangements.
    Sidiropoulou EJ; Paltoglou G; Valsamakis G; Margeli A; Mantzou A; Papassotiriou I; Hassiakos D; Iacovidou N; Mastorakos G
    Sci Rep; 2018 Oct; 8(1):15691. PubMed ID: 30356143
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.